Doximity Inc (NYSE:DOCS) stock rallies 16.60% (As on May 17, 11:13:50 AM UTC-4, Source: Google Finance) after the company surpassed analyst expectations for the first quarter of FY 24. Subscription revenue of $112.7 million, versus $103.2 million, an increase of 9% year-over-year. Non-GAAP net income of $51.0 million, versus $42.1 million, representing a margin of 43.2%, versus 38.0%. Adjusted EBITDA of $56.4 million, versus $48.9 million, an increase of 15% year-over-year, representing adjusted EBITDA margins of 47.8%, versus 44.1%. Operating cash flow of $63.9 million, versus $46.6 million, an increase of 37% year-over-year, and free cash flow of $62.3 million, versus $45.6 million, an increase of 37% year-over-year. The company’s success is attributed to its commitment to providing digital tools for medicine, facilitating collaboration among colleagues, and streamlining clinical workflows. With a network that includes over 80% of U.S. physicians, Doximity aims to enhance productivity and improve patient care through its innovative platform. The company is proud to bring AI and automation to clinical workflows, with over 580,000 unique providers using our workflow tools last quarter.

DOCS in the fourth quarter of FY 24 has reported the adjusted earnings per share of 25 cents, beating the analysts’ estimates for the adjusted earnings per share of 20 cents. The company had reported the adjusted revenue growth of 6 percent to $118.1 million in the fourth quarter of FY 24, beating the analysts’ estimates for revenue of $116.41 million. On top of that, the company’s revenue actually decreased by $17.23 million in Q1 compared to the $21.67 million increase in Q4 CY2023.

Additionally, Doximity also announced a stock repurchase program authorized by its board of directors, allowing for the repurchase of up to $500 million of the company’s Class A common stock. This program has no expiration date and will be subject to general business and market conditions.

Looking ahead, Doximity provided an optimistic financial outlook for fiscal 2025, with revenue projections ranging between $506 million and $518 million, well above the analyst consensus of $473.8 million. The company’s adjusted EBITDA is expected to be between $238 million and $250 million. For the fiscal first quarter ending June 30, 2024, revenue is anticipated to be between $119.5 million and $120.5 million, slightly above the consensus of $119.1 million, with adjusted EBITDA forecasted between $55 million and $56 million.